Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS8 | O00214 | 8/20 | 0.52 |
| ▸ | LGALS3 | P17931 | 6/20 | 0.42 |
| ▸ | LGALS4 | P56470 | 4/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.38 |
| ▸ | LGALS1 | P09382 | 1/20 | 0.38 |
| ▸ | LGALS7; LGALS7B | P47929 | 1/20 | 0.38 |
| ▸ | FGF1 | P05230 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | CA9 | Q16790 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18864321 | 0.86 | LGALS8 (0.47) | LGALS8LGALS3LGALS4LGALS9LGALS1 | |
| SCHEMBL10972064 | 0.81 | LGALS3 (0.46) | LGALS8LGALS3LGALS4 | |
| SCHEMBL17283396 | 0.81 | LGALS8 (0.58) | LGALS8LGALS3LGALS4LGALS9LGALS1 | |
| SCHEMBL2337047 | 0.80 | L3MBTL1 (0.44) | LGALS8ALDH1A1THRB | |
| SCHEMBL27865347 | 0.80 | L3MBTL1 (0.44) | LGALS8ALDH1A1THRB | |
| SCHEMBL701054 | 0.79 | LGALS8 (0.56) | LGALS8LGALS3LGALS4LGALS9LGALS1 | |
| SCHEMBL10825279 | 0.79 | CYP2D6 (0.43) | THRBCA1CA2CA9 | |
| SCHEMBL1674815 | 0.79 | LGALS8 (0.56) | LGALS8LGALS3LGALS4LGALS9LGALS1 | |
| SCHEMBL16327733 | 0.76 | LGALS8 (0.60) | LGALS8LGALS3LGALS4LGALS9LGALS1 | |
| SCHEMBL10781125 | 0.75 | LGALS8 (0.57) | LGALS8LGALS3FGF1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0944639-A4 | SYNTHETIC GLYCOAMINES, METHODS FOR THEIR USE THAT AFFECT CELL | GLINSKII GUENNADI V (US) | 2005-09-28 | — | — | EP | disclosed |
| WO-1999053930-A1 | SYNTHETIC GLYCOAMINES AND METHODS FOR THEIR USE, ALONE OR IN COMBINATION WITH OTHER THERAPIES, THAT AFFECT CELL ADHESION, INHIBIT CANCER CELL GROWTH AND METASTASIS, AND INDUCE APOPTOSIS | GLINSKII GUENNADI V (US) | 1999-10-28 | — | — | WO | disclosed |
| EP-0944639-A1 | SYNTHETIC GLYCOAMINES, METHODS FOR THEIR USE THAT AFFECT CELL | Glinskii, Guennadi, V. (US) | 1999-09-29 | — | — | EP | disclosed |
| WO-1998023625-A9 | SYNTHETIC GLYCOAMINES, METHODS FOR THEIR USE THAT AFFECT CELL | — | 1998-09-17 | — | — | WO | disclosed |
| WO-1998023625-A1 | SYNTHETIC GLYCOAMINES, METHODS FOR THEIR USE THAT AFFECT CELL | GLINSKII GUENNADI V (US) | 1998-06-04 | — | — | WO | disclosed |